leadf
logo-loader
viewSensyne Health PLC

Sensyne Health signs data sharing agreement with NHS Greater Glasgow and Clyde

Sensyne will get access to three separate anonymised patient data sets in three specific disease areas, including cardiovascular disease

Sensyne Health PLC - Sensyne Health signs data sharing agreement with NHS Greater Glasgow and Clyde

Sensyne Health PLC (LON:SENS) has expanded its cache of anonymised health data with the signing of a non-exclusive agreement with NHS Greater Glasgow and Clyde.

The data sharing deal will allow the clinical artificial intelligence company to get access to three separate anonymised patient data sets in three specific disease areas, including cardiovascular disease.

READ: Sensyne Health teams up with Oxford University for high-profile Covid trial

The anonymised patient data will be used by Sensyne to undertake medical research using Clinical AI, improve pharmaceutical development and help deliver better patient care.

NHS Greater Glasgow and Clyde is the largest NHS organisation in Scotland and one of the largest in the UK, including 35 hospitals of different types, serving a population of 1.14mln and employing 39,000 staff.

The agreement falls under the Glasgow Safe Haven partnership between NHS Greater Glasgow and Clyde and the University of Glasgow, designed to provide secure access to NHS and other health datasets derived from diverse sources across the health service.

The Glasgow Safe Haven is accredited by the Scottish Government as an accredited Safe Haven, and is one of four regional Safe Havens across Scotland.

By enabling researchers to link data from different sources, Safe Havens encourage data-driven health research to improve health services, design better treatments, and to create innovative new health products to support better health in Scotland.

“We are delighted to be working with one of the largest NHS Boards in Scotland on data analysis to improve patient care and accelerate medical research,” said chief executive Lord Drayson.

“Adding this data sharing agreement to our Strategic Research Agreements expands our access to anonymised patient data to now cover 3.9mln patients.”

Shares shot up 19% to 69p on Thursday afternoon.

Quick facts: Sensyne Health PLC

Price: 150 GBX

AIM:SENS
Market: AIM
Market Cap: £192.86 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sensyne Health PLC named herein, including the promotion by the Company of Sensyne Health PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE hot on heels of US rally and Rishi gets set to unveil...

FTSE 100 was buoyed early by the record highs seen on Wall Street overnight on the possibility Joe Biden might soon be declared President. London’s blue-chip index rose 35 to 6,461. Later today, Chancellor Rishi Sunak will unveil the government's spending plans for the coming...

2 days, 7 hours ago

2 min read